Related Experiment Video

Updated: Jul 10, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia

Andrica C H de Vries, Ronald W Stam, Christian P Kratz

    Haematologica
    |November 21, 2007
    PubMed

    Insights

    BRAF mutations are not found in juvenile myelomonocytic leukemia (JMML). This study screened 65 JMML patients, concluding BRAF is unlikely to cause JMML.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Juvenile myelomonocytic leukemia (JMML) is a complex blood disorder characterized by myeloproliferative and myelodysplastic features.
    • The Ras-Raf-MEK-ERK signaling pathway is frequently implicated in the pathogenesis of various cancers, including JMML.

    Discussion:

    • This study investigated the role of B-Raf, a key component of the Ras-Raf-MEK-ERK pathway, in JMML.
    • The research screened a cohort of 65 JMML patients for mutations in the BRAF gene.

    Key Insights:

    • No BRAF mutations were identified in any of the 65 JMML patients analyzed.
    • These findings suggest that BRAF mutations do not play a significant role in the development of juvenile myelomonocytic leukemia.

    Outlook:

    • Further research may focus on other components of the Ras-Raf-MEK-ERK pathway or alternative signaling cascades in JMML pathogenesis.
    • Understanding the genetic underpinnings of JMML is crucial for developing targeted therapies.

    More Related Videos

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

    A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

    Published on: December 7, 2014

    Related Concept Videos

    Differentiation of Common Myeloid Progenitor Cells01:15

    Differentiation of Common Myeloid Progenitor Cells

    Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...